Moderna, Inc. - Common Stock (MRNA)

Breaking news: Moderna isn't just a "pandemic stock" after all.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 20% in the morning session after investors took profits as the stock surged over 17...

The biotech could be on the verge of setting a new standard of care for skin cancer.

Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA submission.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, develop...

Most stocks rose Wednesday, but a few big tech names told a different story. Here's what split the market again.

Pfizer Inc (NYSE:PFE) shares are trading higher Wednesday, moving in sympathy with mRNA cancer vaccine-related companies after Merck & Co Inc (NYSE:MRK) and Moderna Inc (NASDAQ:MRNA) announced that their combination therapy of intismeran autogene and Keytruda showed positive recurrence-free survival results in melanoma patients.

The treatment combines an mRNA shot with Merck's Keytruda.